Posted by: Northwest Eye in can eyes be transplanted on March 10, 2026
A full-eye transplant is still experimental
A full-eye transplant remains a research effort rather than an established treatment as of November 10, 2026. Only parts of the eye, most commonly the cornea, are currently used for transplantation. A reported whole-eye procedure showed that a transplanted eye could remain viable and retain some retinal responses, but it did not restore sight.
The first reported combined whole-eye and partial-face transplant took place in May 2023 after a 46-year-old man lost his left eye in a high-voltage electrical injury. This was a landmark surgical procedure, but it does not mean that whole-eye transplantation is available as a routine way to restore vision. The procedure preserved important eye structures without demonstrating useful sight.
The distinction matters if you are asking about treatment for blurred vision, cataracts, corneal disease, or severe vision loss. A research procedure and an established clinical option are not the same thing. Your next step depends on which part of your eye is causing the vision problem.
Over 70,000 people in the United States donate their eyes after death each year, but only parts of those donated eyes—most commonly the front surface, or cornea—are currently used for transplantation. The figure measures eye donations in the United States, not the number of whole eyes transplanted or the number of people who regain sight.
Earlier results also show why expectations need care. A review listed a 1971 living-human whole-eye transplantation case in which 0 of 1 eyes, meaning none of the one transplanted eyes, recovered visual function.
Research continues because people with damage to the retina or optic nerve may have few ways to regain lost vision. For now, whole-eye transplantation is aimed at future sight restoration. It is not a standard replacement for cataract surgery or a corneal transplant.
What a whole-eye transplant would have to reconnect
A whole-eye transplant would need more than placing a donor eye inside the eye socket. The eye’s nerves, muscles, and blood vessels would need to reconnect with the brain so that the eye could function for sight.
The optic nerve is the main pathway that carries visual information from the eye to the brain. When light reaches the retina, the information must travel through this pathway before your brain can interpret it as vision. A transplanted eye therefore needs a working connection between its retina and the recipient’s brain.
The operation would also involve restoring blood flow and maintaining the eye’s physical connections. Keeping the eye alive is one task. Creating a connection that carries visual information in a useful way is a different task. The reported human procedure addressed important surgical and blood-flow problems, but sight still was not restored.
Researchers have described reconnecting and regenerating the optic-nerve pathway as a major challenge in whole-eye transplantation. The difficulty is not limited to attaching the cut ends of a nerve. The nerve fibers must grow in the right direction and connect with the right targets in the brain. Current evidence does not show that this process can reliably restore sight after a whole-eye transplant.
This is why a corneal transplant and a whole-eye transplant are fundamentally different procedures. A corneal transplant replaces damaged tissue at the front of the eye. A whole-eye transplant would require a functioning connection through the optic nerve and into the brain.
Why the optic nerve is the hardest part
The optic nerve is the hardest part because it must carry visual information from a transplanted eye into the brain. In the cited research, circulation was restored and the optic nerve was reconnected, but the optic-nerve neurons did not grow back under normal conditions.
Retinal neurons also have poor capacity for self-repair after damage and cannot self-regenerate. These cells include photoreceptors, which respond to light, and retinal ganglion cells, which help send information toward the optic nerve. Replacing or preserving the eye is not enough if the damaged cells and nerve pathway cannot communicate with the brain.
Past results illustrate the gap between an attached eye and restored vision. In a cited review, the 1971 living-human case had 0 of 1 eyes recover visual function. The same review reported that 0 of 24 rats regained vision in a listed 1924 study.
Reports of that 1924 rat study differ on whether 24 or 25 rats were included. Both accounts report that no rat regained vision. One account also reports that 2 of 25 eyes recovered a corneal reflex, which is a response of the eye and not the same as useful sight. This difference in reported study size does not change the central result: visual recovery was not demonstrated in those animals.
These findings do not predict what every future technique will achieve. They do show why researchers treat nerve regeneration as a separate problem from surgical transplantation. Until that pathway can be repaired and connected accurately, a viable donor eye may still fail to provide vision.
What the landmark human procedure showed
The landmark human procedure showed that a transplanted eye could remain alive and retain some retinal function without restoring sight. The combined whole-eye and partial-face transplant was performed in May 2023 after a 46-year-old man suffered a high-voltage electrical injury, severe facial injuries, and removal of his left eye.
The procedure lasted 22 hours, and hospital discharge occurred on day 25. At the one-year follow-up, the study reported no acute rejection, infectious episodes, newly developed donor-specific antibodies, or other adverse events. Those findings describe this one reported transplant and do not establish a general outcome for future patients.
The transplanted eye maintained normal eye pressure and blood flow. It had a normal appearance, preserved retinal cell layers, and a visible photoreceptor layer at one year. Testing also showed that the retina responded to light.
Doctors used several tests to examine different parts of the visual system:
- Electroretinography measured the retina’s electrical response to light.
- Visual evoked potentials assessed signals related to the visual pathway.
- Functional MRI showed related activity in the visual cortex, the brain area involved in processing visual information.
The results were encouraging for surgical research but limited for vision. The retina responded to light, and functional MRI showed related activity in the visual cortex, but sight had not been restored.
The most useful way to understand this case is to separate three outcomes: keeping the eye supplied with blood, preserving retinal structures and responses, and restoring sight. The procedure demonstrated the first two in the reported recipient. It did not demonstrate the third. Whole-eye transplantation therefore remains experimental rather than an established option for treating ordinary vision loss.

Why someone might ask about an eye transplant
You may ask about transplantation when vision becomes blurred, distorted, hazy, or severely reduced. Different eye conditions affect different tissues, so the word “transplant” can refer to very different procedures.
Keratoconus can thin and reshape the cornea, the clear front surface of the eye. This can cause distorted, blurred, or hazy vision. Glasses or contact lenses may help early, while a cornea transplant may be needed as the condition worsens.
Cataracts affect the lens inside the eye. A cataract can make the lens cloudy and your vision blurred. Cataract surgery addresses the cloudy lens rather than replacing the whole eye.
Retinal or optic-nerve disease can cause more severe vision loss because these tissues are involved in sending or processing visual signals. One cited review reported that more than 40 million people worldwide were legally blind from retinal or optic-nerve disease. That figure measures a worldwide disease burden; it does not mean that every person in that group is a candidate for transplantation.
Other research has tested more limited approaches aimed at retinal disease. One report described transplanting human embryonic stem-cell-derived retinal pigment epithelium cells beneath the retina on ultrathin sheets. One year later, many patients reported a gain of more than five letters in best-corrected visual recovery in the treated eye and a loss of more than five letters in the untreated eye. Those figures measure changes on a visual-acuity test in that research setting, not restored sight from a whole-eye transplant.
In the United States, doctors perform 47,000 corneal transplants each year. This number measures corneal procedures, not full-eye transplants.
The practical question is not simply whether an eye can be replaced. It is which tissue is affected and whether an established treatment addresses that tissue.
A corneal transplant replaces corneal tissue
A corneal transplant replaces damaged corneal tissue with healthy donor tissue. The medical name for corneal transplantation is keratoplasty, and it is the most common type of transplantation performed worldwide. Corneal transplantation is also used to treat corneal blindness.
The surgeon does not always replace the entire cornea. The procedure depends on which corneal layer is damaged:
- A penetrating keratoplasty replaces the entire cornea.
- A deep anterior lamellar keratoplasty replaces part of the cornea.
- An endothelial keratoplasty replaces the inner corneal barrier.
These procedures are different from a full-eye transplant because they replace a defined area of corneal tissue. They do not require replacing the retina, optic nerve, muscles, and blood vessels connected with the whole eye.
The results of a corneal transplant still depend on the condition being treated and the risk level of the case. In one study of 52 patients with high-risk corneal transplants, 78 procedures were performed. Infections accounted for 59.6% of the indications for the first keratoplasty, while trauma accounted for 21.2%. The percentages measure the reasons for the first procedure in that study population, not all corneal transplants.
That study reported graft survival of 54% at one year and 19.8% at five years. Graft survival measures whether the transplanted tissue remained in place and functioning according to the study’s definition; it does not guarantee normal vision. The study also reported that visual acuity, a measure of visual clarity, changed from 2.05 logMAR on the day of surgery to 1.66 logMAR at the latest examination.
A corneal transplant can therefore be an established treatment for selected corneal problems, but it is not a substitute for a full-eye transplant when the retina or optic nerve is the source of vision loss.
Cataract surgery replaces the cloudy lens
Cataract surgery removes the cloudy natural lens and replaces it with a clear artificial lens called an intraocular lens. We perform cataract surgery as an outpatient procedure. Your vision may be blurry for a short time while your eye heals and adjusts.
A cataract is different from a damaged cornea or optic nerve. The lens sits behind the cornea and focuses light. When the lens becomes cloudy, replacing that lens can address the source of the blur. When cataracts impair vision, surgery is the only treatment option.
We determine cataract treatment based on the type and severity of the cataract. When discussing cataract-surgery options, we consider your eye health, cornea, goals, and tolerance for visual trade-offs. These details help separate a lens problem that cataract surgery may address from a vision problem caused by another part of the eye.
We also assess factors such as your age, other eye diseases, prior surgery, trauma, and cataract complexity because they can affect complication risk. This assessment is specific to your eyes. It is not a decision that can be made from the idea of an eye transplant alone.
For context, a 2021-dollar estimate for penetrating keratoplasty—not cataract surgery—was $22,783 for people under 65 and $20,223 for people 65 or older. Those figures measure an older estimated cost for a corneal procedure and should not be treated as a cataract-surgery price.
If your main concern is cloudy or blurred vision, an eye examination can distinguish a lens problem from a corneal, retinal, or optic-nerve problem. That distinction determines which established conversation makes sense.
What transplantation can cost
A typical price for a full-eye transplant is not established as a routine patient cost because whole-eye transplantation remains experimental. A quoted amount for research would not be comparable to the price of an established corneal or cataract procedure.
Corneal-transplant estimates are more available, but they still vary. That range measures a reported U.S. cost estimate without insurance. The price depends partly on whether surgery is performed in an outpatient center or a hospital, and it can also vary by facility.
The main factors that can change a corneal-transplant cost include:
- The type and severity of the corneal condition.
- The transplant technique, such as replacing the entire cornea or only a corneal layer.
- The complexity and length of the surgery.
- The facility where the procedure takes place.
- Whether you have insurance and what that coverage includes.
For specific corneal techniques, average estimates are stated in 2021 dollars. For penetrating keratoplasty, the estimate was $22,783 for people under 65 and $20,223 for people 65 or older. For endothelial keratoplasty, the estimate was $25,248 for people under 65 and $19,693 for people 65 or older. These figures measure historical estimates for named corneal procedures, not current prices for every facility or an estimate for your care.
Some facilities may have offered a 10% to 30% discount to people without insurance for corneal-transplant surgery, but that figure describes a possibility reported by the cited source, not a guaranteed discount.
Use cost information only after the affected tissue and appropriate procedure are clear. A corneal-transplant estimate cannot tell you whether you need a corneal procedure, cataract surgery, or another form of eye care.
Know when an eye problem needs urgent help
Sudden vision changes or an eye injury need prompt attention from qualified eye or emergency care. Please do not use our contact form for an ocular emergency.
Do not wait for a routine discussion if your eye has been injured or your vision changes suddenly. Seek immediate qualified help instead. If you are considering an experimental procedure, discuss it with an appropriate specialist rather than treating an online description as a treatment plan.
Some corneal problems can also require urgent treatment. Keratoplasty may need to be performed urgently when an infection does not respond to conservative treatment, trauma endangers the eyeball, or corneal opacity prevents examination of the eyeball. These are specific situations described in the medical literature, not a checklist for diagnosing yourself.
A high-risk corneal-transplant study reported mean observation without complications of 23 months after the first surgery, 13 months after the second, and 14 months after the third. Those durations describe that study’s follow-up groups. They are not a promise about how long a graft will last or a reason to delay care for a new symptom.
For an urgent problem, use the emergency route recommended by your local health system or seek immediate eye care. Use a routine appointment request for a nonurgent examination and discussion of treatment options.

Arrange an eye examination for your vision problem
Before a corneal transplant, your ophthalmologist discusses why you need it, how it may help, and what to expect. An examination can support a discussion of your vision problem and which established options, if any, fit your eye health and goals.
The appointment should focus first on the affected part of the eye. Your discussion may include:
- Whether the main concern involves the lens, cornea, retina, optic nerve, or another structure.
- Whether an established procedure applies to that tissue.
- What the procedure is designed to address and what it cannot address.
- Which eye-health factors, prior procedures, injuries, or other conditions affect the discussion.
- What uncertainty remains if you are asking about experimental treatment.
If cataracts impair your vision, the cited Northwest Eye information identifies surgery as the only treatment option. We determine cataract treatment based on the type and severity of the cataract, then consider your eye health, cornea, goals, and tolerance for visual trade-offs.
If a corneal procedure is being discussed, keep the cost figures in context. One estimate for endothelial keratoplasty was $25,248 for people under 65 and $19,693 for people 65 or older in 2021 dollars. The 2011 estimates were $20,953 and $16,343, respectively, for the 2011 estimates before adjustment. These figures measure historical estimates for one corneal technique and do not determine your current cost.
An examination cannot make an experimental procedure established. It can help you identify the problem being evaluated and discuss available care without assuming that a whole-eye transplant is the answer.
Book the next conversation about your vision
Whole-eye transplantation remains experimental, and the reported human procedure did not restore sight. Established procedures address specific tissues, such as the cornea or cloudy lens, so an eye examination is the practical way to discuss what may fit your vision problem and goals. A qualified eye professional must decide whether a treatment is suitable for your eyes.
At Northwest Eye, we can discuss your vision problem and established treatment options during an eye examination in Minnetonka. Do not use the routine contact form for an ocular emergency.
Questions to ask about eye transplantation and available treatments
Can eyes be transplanted as a routine treatment today?
No. Whole-eye transplantation remains experimental rather than an established treatment, and the reported landmark procedure did not restore sight. Current transplantation usually replaces specific tissue, most commonly the cornea. Research aims to solve the problems of keeping a donor eye alive and reconnecting its visual pathway with the brain.
How is a whole-eye transplant different from a corneal transplant or cataract surgery?
A whole-eye transplant would replace the entire eye and reconnect its nerves, muscles, and blood vessels. A corneal transplant replaces damaged tissue on the eye’s clear front surface. Cataract surgery removes a cloudy natural lens and replaces it with a clear artificial lens. The appropriate discussion depends on which eye tissue is affected.
What does a corneal transplant typically cost?
A cited U.S. estimate places an uninsured corneal transplant between $3,900 and $28,000. The amount can vary with the condition’s severity, transplant technique, surgical complexity, facility, and insurance coverage. These figures do not provide a price for a whole-eye transplant, because that procedure is not an established routine treatment.
When should I arrange an eye examination if I am considering transplantation?
Arrange an eye examination for ongoing blurred vision, vision loss, or cataract concerns. The examination can help identify whether the lens, cornea, retina, optic nerve, or another structure is involved. It also allows you to discuss established options, their limits, and whether an experimental treatment claim applies to your situation.
What should I do if my vision changes suddenly or my eye is injured?
Seek immediate qualified eye or emergency care for sudden vision changes or an eye injury rather than waiting for a routine appointment. Do not use Northwest Eye’s routine contact form for an ocular emergency. If you are considering experimental treatment, discuss it with an appropriate specialist instead of treating online information as a treatment plan.





